SUBSCRIBE
SUBSCRIBE
News   Business

Kyowa Hakko Kogyo Co., Ltd. To Introduce Self-Injectable Drug For Treating Parkinson’s Disease From Britannia Pharmaceuticals Limited

February 23, 2006 | 
1 min read
Tokyo, Feb 23, 2006 (JCN) - Kyowa Hakko Kogyo announced on February 22 that it has concluded a licensing agreement with UK company Britannia Pharmaceuticals for a self-injectable formulation of apomorphine.
Alliances Asia
MORE ON THIS TOPIC
Illustration of cardboard box filled with office supplies, a computer keyboard, lamp, and a potted plant
Layoff Tracker
Pfizer, Geron Downsize To Streamline Costs
December 12, 2025
 · 
95 min read
 · 
BioSpace Editorial Staff
Creative collage illustration of financial business. Two businessmen shaking hands for partners agreement. Conceptual illustration of success deal, corporate ethic, connection.
Weight loss
Zealand Bets up to $2.5B in Metabolic Pact With Chinese Biotech
December 11, 2025
 · 
2 min read
 · 
Tristan Manalac
Pictured: Pfizer's signage outside its office in Canada/iStock, JHVEPhoto
Layoffs
Pfizer’s Cost Cuts Claim 200+ Jobs in Switzerland: Report
December 11, 2025
 · 
2 min read
 · 
Tristan Manalac
Podcast
Weight Loss Waves, Pazdur’s Exit and FDA Instability, New Neuro Breakthroughs
December 10, 2025
 · 
1 min read
 · 
Heather McKenzie